Please note that some translations using Google Translate may not be accurately represented, and image captions and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result for using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Ross Berkowitz, MD, is the co-director of the New England Trophoblastic Disease Center at Dana-Farber/Brigham and Women's Cancer Center, affiliated with the Susan F. Smith Center for Women's Cancers. For
over 20 years, Dr. Berkowitz has focused his research and care on GTD, and has published more than 250 original reports and reviews on this disease – including his studies of risk factors and improved therapies.
Neil Horowitz, MD, is a board certified gynecologic oncologist who practices closely with the founders of the New England Trophoblastic Disease Center. As Director of Clinical Research in Gynecologic Oncology,
Dr. Horowitz's work has included several ongoing research projects on GTD.
Your entire care team has extensive experience in caring for patients with gynecologic cancers. Our specialists work closely together and collaborate regularly to ensure that your care plan offers the best possible outcomes and that all your needs are
Learn more about our team of gynecological cancer specialists.
Appointments and Second Opinions